Srikanth Venkatraman and his team at Merck & Co. are the recipients of the 2012 Heroes of Chemistry Award for developing the chronic hepatitis C drug Victrelis^®.  His research team is one of three scientific teams to be granted this prestigious ACS award.  Detailed information found here.